CORTNEY WHITE: Open Payments
NPI 1821479767 · ASHDOWN, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$750 in 30 payments from 12 companies in 2025. Trend: 2023 $373 · 2024 $421 · 2025 $750
Food & beverage: $561Education: $189
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $226 |
| Novo Nordisk Inc | 4 | $69 |
| PFIZER INC. | 3 | $62 |
| ABBVIE INC. | 3 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| Lilly USA, LLC | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Ferring Pharmaceuticals Inc. | 1 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $52 |
| Biogen, Inc. | 1 | $25 |
Products named: Rybelsus, CAPLYTA, TRINTELLIX, QULIPTA, ELIQUIS, Veozah, JARDIANCE, BREZTRI.
Industry payments across AR — which companies pay providers there.
